Insider Trading Alert - AMGN, ACM And CWEI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, May 12, 2014, 142 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $463.50 to $302,316,738.76.

Highlighted Stocks Traded by Insiders:

Amgen (AMGN) - FREE Research Report

Bradway Robert A, who is Chairman, CEO and President at Amgen, bought 894 shares at $111.77 on May 12, 2014. Following this transaction, the Chairman, CEO and President owned 185,013 shares meaning that the stake was reduced by 0.49% with the 894-share transaction.

The shares most recently traded at $111.48, down $0.29, or 0.26% since the insider transaction. Historical insider transactions for Amgen go as follows:

  • 4-Week # shares sold: 1,873
  • 12-Week # shares sold: 1,873
  • 24-Week # shares sold: 1,873

The average volume for Amgen has been 3.8 million shares per day over the past 30 days. Amgen has a market cap of $84.4 billion and is part of the health care sector and drugs industry. Shares are down 2.06% year-to-date as of the close of trading on Monday.

Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine worldwide. The stock currently has a dividend yield of 2.19%. The company has a P/E ratio of 18.1. Currently, there are 9 analysts who rate Amgen a buy, no analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMGN - FREE

TheStreet Quant Ratings rates Amgen as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Amgen Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

AECOM Technology (ACM) - FREE Research Report

Ouchi William G, who is Director at AECOM Technology, sold 3,537 shares at $31.55 on May 12, 2014. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 3,537-share transaction.

The shares most recently traded at $32.53, up $0.98, or 3.01% since the insider transaction. Historical insider transactions for AECOM Technology go as follows:

  • 4-Week # shares sold: 28,000
  • 12-Week # shares bought: 1
  • 12-Week # shares sold: 86,442
  • 24-Week # shares bought: 1
  • 24-Week # shares sold: 157,142

The average volume for AECOM Technology has been 632,900 shares per day over the past 30 days. AECOM Technology has a market cap of $3.2 billion and is part of the services sector and diversified services industry. Shares are up 10.77% year-to-date as of the close of trading on Monday.

AECOM Technology Corporation, together with its subsidiaries, provides professional technical and management support services for public and private clients in worldwide. The company operates through two segments, Professional Technical Services (PTS) and Management Support Services (MSS). The company has a P/E ratio of 13.0. Currently, there are 2 analysts who rate AECOM Technology a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACM - FREE

TheStreet Quant Ratings rates AECOM Technology as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, increase in stock price during the past year, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full AECOM Technology Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Clayton Williams Energy (CWEI) - FREE Research Report

Parker Robert L, who is Director at Clayton Williams Energy, sold 9,449 shares at $138.87 on May 12, 2014. Following this transaction, the Director owned 19,768 shares meaning that the stake was reduced by 32.34% with the 9,449-share transaction.

The shares most recently traded at $129.70, down $9.17, or 7.07% since the insider transaction. Historical insider transactions for Clayton Williams Energy go as follows:

  • 4-Week # shares sold: 439
  • 12-Week # shares sold: 439
  • 24-Week # shares sold: 439

The average volume for Clayton Williams Energy has been 84,900 shares per day over the past 30 days. Clayton Williams Energy has a market cap of $1.6 billion and is part of the basic materials sector and energy industry. Shares are up 60.39% year-to-date as of the close of trading on Monday.

Clayton Williams Energy, Inc., an independent oil and gas company, explores for and produces oil and natural gas primarily in Texas, Louisiana, and New Mexico. The company has a P/E ratio of 56.7. Currently, there are 3 analysts who rate Clayton Williams Energy a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CWEI - FREE

TheStreet Quant Ratings rates Clayton Williams Energy as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, good cash flow from operations, compelling growth in net income and solid stock price performance. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Clayton Williams Energy Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI

P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Video: The S&P 500 Is Failing to Make New Highs

Video: The S&P 500 Is Failing to Make New Highs

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump